Daiichi Sankyo and AstraZeneca’s Enhertu Receives the US FDA’s Approval for the Treatment of HER2 Mutant Metastatic Non-Small Cell...
Shots: The approval was based on the results from the P-II (DESTINY-Lung02) trial...
Argenx’s Vyvgart Receives the EC’s Approval for the Treatment of Generalized Myasthenia Gravis
Shots: The approval was based on the results from the P-III (ADAPT) trial evaluati...
BridgeBio, Sentynl, and Medison Reports the Approval of Nulibry in Israel for the Treatment of Molybdenum Cofactor Deficiency Type...
Shots: The approval was based on the results from 3 studies evaluating the efficac...
Eli Lilly Reports the Availability of Taltz (ixekizumab) as New Citrate-Free Formulation to Reduce Injection Site Pain in the US
Shots: Taltz has been approved in the US in May 2022 to treat adults & childre...
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) Receive the US FDA’s Approval as First HER2-Directed Therapy for...
Shots: The approval was based on the P-III (DESTINY-Breast04) trial evaluating Enh...
Myovant and Pfizer’s Myfembree Receive the US FDA’s Approval for the Treatment of Pain Associated with Endometriosis
Shots: The approval was based on the 1yr. efficacy & safety data incl. P-III (...
